Clinical Study
Prognosis of Multifocal Papillary Thyroid Carcinoma
Table 2
Multifocal papillary thyroid carcinoma in postoperative progression and progression-free groups.
| ā | Postoperative progression | Postoperative progression-free | value |
| Age (yr) | | | 0.2128 | Female (%) | 61 (62.2) | 323 (83.9) | 0.0001 | Tumor size (cm) | | | 0.0001 | TNM stage I at diagnosis (%) | 42 (42.9) | 263 (68.3) | 0.0001 | Postoperative Tg* (ng/dL) | | | 0.0001 | Follow-up period (yr) | | | 0.0277 | Thyroid cancer mortality (%) | 18 (18.4) | 0 | 0.0001 | Total mortality (%) | 21 (21.4) | 13 (3.4) | 0.0001 |
|
|
Tg*: serum thyroglobulin levels 4 to 6 weeks after thyroidectomy.
|